WCM Investment Management LLC lowered its holdings in Novanta Inc. (NASDAQ:NOVT - Free Report) by 4.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 186,832 shares of the technology company's stock after selling 9,664 shares during the quarter. WCM Investment Management LLC owned 0.52% of Novanta worth $21,129,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in NOVT. Summit Creek Advisors LLC raised its stake in Novanta by 47.5% during the 4th quarter. Summit Creek Advisors LLC now owns 73,673 shares of the technology company's stock valued at $8,766,000 after purchasing an additional 23,712 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in Novanta by 75.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,399,462 shares of the technology company's stock worth $155,536,000 after purchasing an additional 604,055 shares during the last quarter. Legal & General Group Plc grew its position in Novanta by 7.8% in the 4th quarter. Legal & General Group Plc now owns 207,053 shares of the technology company's stock worth $24,637,000 after purchasing an additional 14,969 shares during the last quarter. Truist Financial Corp increased its holdings in shares of Novanta by 337.2% during the 4th quarter. Truist Financial Corp now owns 9,963 shares of the technology company's stock worth $1,185,000 after purchasing an additional 7,684 shares during the period. Finally, Thrivent Financial for Lutherans increased its holdings in shares of Novanta by 484.8% during the 4th quarter. Thrivent Financial for Lutherans now owns 48,336 shares of the technology company's stock worth $5,752,000 after purchasing an additional 40,071 shares during the period. 98.35% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities analysts recently issued reports on NOVT shares. Robert W. Baird set a $180.00 price target on Novanta in a research note on Tuesday, June 9th. Wall Street Zen raised shares of Novanta from a "hold" rating to a "buy" rating in a report on Saturday, June 27th. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Novanta in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $180.00.
Check Out Our Latest Research Report on NOVT
Novanta Price Performance
NASDAQ:NOVT opened at $148.71 on Monday. Novanta Inc. has a 1-year low of $98.27 and a 1-year high of $171.85. The stock has a market capitalization of $5.62 billion, a PE ratio of 107.76 and a beta of 1.67. The firm has a fifty day simple moving average of $156.51 and a 200 day simple moving average of $139.33. The company has a current ratio of 3.56, a quick ratio of 2.69 and a debt-to-equity ratio of 0.15.
Novanta (NASDAQ:NOVT - Get Free Report) last released its earnings results on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.78 by $0.03. The business had revenue of $257.71 million during the quarter, compared to analysts' expectations of $253.40 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The firm's revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.74 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. On average, research analysts expect that Novanta Inc. will post 3.59 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, CEO Matthijs Glastra sold 7,500 shares of the firm's stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total value of $1,128,225.00. Following the transaction, the chief executive officer owned 42,761 shares of the company's stock, valued at approximately $6,432,537.23. This trade represents a 14.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.20% of the company's stock.
About Novanta
(
Free Report)
Novanta, Inc NASDAQ: NOVT is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta's product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta's Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Featured Articles
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Novanta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.
While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
